Phase I study of midostaurin and azacitidine in relapsed and elderly AML.
Brenda W. Cooper
Research Funding - Celgene; Novartis
Tamila L. Kindwall-Keller
No relevant relationships to disclose
Hillard M. Lazarus
No relevant relationships to disclose
Mehdi Hamadani
No relevant relationships to disclose
William W. Tse
No relevant relationships to disclose
Soumit K. Basu
No relevant relationships to disclose
Michael Craig
No relevant relationships to disclose